In vitro synergy of colistin combinations against extensively drug-resistant Acinetobacter baumannii producing OXA-23 carbapenemase

被引:26
|
作者
Wei, Wenjuan [1 ]
Yang, Haifei [1 ]
Liu, Yanyan [1 ,2 ,3 ]
Ye, Ying [1 ,2 ,3 ]
Li, Jiabin [1 ,2 ,3 ]
机构
[1] Anhui Med Univ, Affiliated Hosp 1, Dept Infect Dis, Jixi Rd 218, Hefei, Peoples R China
[2] Anhui Med Univ, Inst Bacterium Resistance, Hefei, Peoples R China
[3] Anhui Ctr Surveillance Bacterial Resistance, Hefei, Peoples R China
基金
美国国家科学基金会;
关键词
Antimicrobial resistance; Acinetobacter; Synergy; Susceptibility; Combination therapy; MOLECULAR EPIDEMIOLOGY; SULBACTAM; FOSFOMYCIN; TIGECYCLINE; IMIPENEM; RIFAMPIN; MULTICENTER; INFECTION; EFFICACY; PLUS;
D O I
10.1179/1973947815Y.0000000030
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Fifty extensively drug-resistant Acinetobacter baumannii (XDRAB) were isolated from patients. The chequerboard microdilution method was used to determine the in vitro activities of five colistin (COL)based combinations including COL+fosfomycin (FOS), COL+rifampicin (RIF), COL+imipenem (IMP), COL+sulbactam (SUP) and COL+levofloxacin (LVX). The synergistic activity was evaluated by the fractional inhibitory concentration index (FICI). According to our results, the combination of COL was synergistic with FOS, RIF, IMP, SUP and LVX with the ratios of 50, 72, 88, 92 and 64%, respectively. When combined with COL, the other five agents showed increased antimicrobial activities. In addition, two of the combinations, COL+RIF and COL+IMP, were more active than the combinations of COL+FOS, COL+SUP and COL+LVX. More importantly, these combination regimens could exert synergistic effects at the sub-minimum inhibitory concentration (MIC) levels against XDRAB strains.
引用
收藏
页码:159 / 163
页数:5
相关论文
共 50 条
  • [21] Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia
    Khawcharoenporn, Thana
    Pruetpongpun, Nattapol
    Tiamsak, Pimsiri
    Rutchanawech, Sasinuch
    Mundy, Linda M.
    Apisarnthanarak, Anucha
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2014, 43 (04) : 378 - 382
  • [22] Synergistic effects of bacteriophage cocktail and antibiotics combinations against extensively drug-resistant Acinetobacter baumannii
    Rastegar, Sanaz
    Skurnik, Mikael
    Tadjrobehkar, Omid
    Samareh, Ali
    Samare-Najaf, Mohammad
    Lotfian, Zahra
    Khajedadian, Maryam
    Hosseini-Nave, Hossein
    Sabouri, Salehe
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [23] Outbreak of carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a Tertiary Care Hospital of Papeete, French Polynesia
    Naas, T
    Levy, M
    Hirschauer, C
    Marchandin, H
    Nordmann, P
    JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (09) : 4826 - 4829
  • [24] Imported cases of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemase in Belgium:: characterisation and unusual loss of resistance
    Bogaerts, P.
    Naas, T.
    Bauraing, C.
    Deplano, A.
    Pierard, D.
    Nordmann, P.
    Glupczynski, Y.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S268 - S268
  • [25] Imported cases of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemase in Belgium:: characterisation and unusual loss of resistance
    Bogaerts, P.
    Naas, T.
    Bauraing, C.
    Deplano, A.
    Pierard, D.
    Nordmann, P.
    Glupczynski, Y.
    ACTA CLINICA BELGICA, 2007, 62 (06) : 457 - 457
  • [26] Nosocomial Outbreak of a Multiresistant Acinetobacter baumannii Expressing OXA-23 Carbapenemase in Spain
    Merino, Maria
    Poza, Margarita
    Roca, Ignasi
    Jose Barba, Maria
    Dolores Sousa, Maria
    Vila, Jordi
    Bou, German
    MICROBIAL DRUG RESISTANCE, 2014, 20 (04) : 259 - 263
  • [27] Structural Basis for Carbapenemase Activity of the OXA-23 β-Lactamase from Acinetobacter baumannii
    Smith, Clyde A.
    Antunes, Nuno Tiago
    Stewart, Nichole K.
    Toth, Marta
    Kumarasiri, Malika
    Chang, Mayland
    Mobashery, Shahriar
    Vakulenko, Sergei B.
    CHEMISTRY & BIOLOGY, 2013, 20 (09): : 1107 - 1115
  • [28] In Vitro Synergy of Colistin Combinations against Colistin-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae Isolates
    Vidaillac, Celine
    Benichou, Lothaire
    Duval, Raphael E.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (09) : 4856 - 4861
  • [29] In vivo activity of co-trimoxazole combined with colistin against Acinetobacter baumannii producing OXA-23 in a Galleria mellonella model
    Khalil, Mahmoud A. F.
    Moawad, Sawsan S.
    Hefzy, Enas M.
    JOURNAL OF MEDICAL MICROBIOLOGY, 2019, 68 (01) : 52 - 59
  • [30] In vitro activities of sitafloxacin tested alone and in combination with rifampin, colistin, sulbactam, and tigecycline against extensively drug-resistant Acinetobacter baumannii
    Dong, Xiaomeng
    Chen, Fengzhe
    Zhang, Yajun
    Liu, Haihong
    Liu, Yongjuan
    Ma, Lixian
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (05): : 8135 - 8140